Purchase Order 75N94020P00891
Award Date 9/25/20
Potential Completion Date 9/24/21
Potential Value $21K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
India
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to JAI Research Foundation on July 1, 2026, for preclinical toxicity testing services valued at $58,200.00, with completion by June 30, 2027. Work is performed in India. The order covers toxicity testing for novel drugs to support drug discovery within the Laboratory of Bioorganic Chemistry, focusing on solubility and bioavailability assessments. The procurement emphasizes protocol consistency with...
- <p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a firm fixed price purchase order to JAI Research Foundation on September 22, 2018, with a ceiling value of $17,754.24. Place of performance is India. The order ultimate completion date was March 22, 2019.</p>
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, awarded a $16,000 firm-fixed-price purchase order to Imquest Biosciences, Inc., a for-profit preclinical contract research and development organization, for "NIDDK - HIV CYTOPROTECTION ASSAYS 16 COMPOUNDS." The contract has an ultimate completion date of August 31, 2023, and was not set aside for any specific business categories....
- This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to GVK Biosciences Private Limited, a for-profit organization, with a ceiling value of $20,020.00. The contract was awarded on June 29, 2015, with a performance period ending on December 31, 2015. The contract type is a Firm Fixed Price Purchase Order, and it does not have a set-aside designation. The place of performance is India. This award appears to be...
- <p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to GVK Biosciences Private Limited for $24,900.00 on August 18, 2017. The order procures chemical stability testing using simulated gastric and intestinal fluids, with work performed in India under firm fixed price terms. The order completion date is October 12, 2017.</p>
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $88,000 firm fixed price purchase order to Frontage Laboratories, Inc., a full-service contract research organization, to provide specialized pharmacokinetic and metabolism research services. The contract supports NIDDK's efforts to advance the testing of a new class of antiviral molecules by conducting blood stability studies, rat and mouse pharmacokinetic studies, and in vitro hepatocyte metabolism studies...
- This firm fixed price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). Valued at $155,100, the contract calls for Frontage Laboratories Inc. to provide services in support of compound 21 testing and in vivo pharmacokinetics studies. Specifically, the prime contractor will scale up production of compound 21 to deliver 10...
- This is a firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Children's Research Institute, a subsidiary of the Children's National Medical Center, for $23,332.97. The contract is for research recruitment and services related to the NIDDK Youth and Young Adult Diabetes Research Program. The work will be performed in Washington, D.C. and has a completion date of September 27, 2023. This contract award does...
- <p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Vanderbilt University for $15,799.25 on June 5, 2020, for animal testing, with completion by September 10, 2020. Performance occurs at Bethesda, Maryland. The order carries firm fixed-price pricing and no set-aside designation.</p>
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), an institute of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), awarded a $24,948 purchase order to Phoenixbio Co., LTD. of Japan. The firm fixed price contract is for the delivery of 18 plates of 24-well plates containing PXBCELLS to support NIDDK research efforts. The one year contract runs from September 2, 2023 through September 1, 2024 and will be performed in...
This is a $20,960 fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to the JAI Research Foundation, a non-profit organization. The contract is for solubility, stability, and toxicology studies to advance novel drug candidates developed by the NIDDK into clinical trials. This contract was awarded on September 25, 2020 and has a completion date of September 24, 2021. The contract stems from a small business sources sought notice (NICHD-20-231) posted on August 11, 2020, which did not utilize a set-aside. The work is to be performed in India.
Generated 3/4/25, 11:18 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Solubility stability and toxicology studies are needed to advance NIH developed novel drug candidates into the clinical arena | NICHD-20-231 | Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development | Pre-Solicitation 2/2 | 9/11/20, 8:07 PM | |
Solubility stability and toxicology studies are needed to advance NIH developed novel drug candidates into the clinical arena | NICHD-20-231 | Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development | Pre-Solicitation 1/2 | 8/11/20, 4:03 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($21k) | 3/3/25 | |
| Not listed | Not listed | $41.9k | 9/24/20 |